Onychomycosis Treatment Market - Forecast(2019 - 2024)

Report Code: HCR 0328 Report Format: PDF + Excel (Delivery in 48 Hrs)
Onychomycosis is a nail infection caused by fungus–Trichophyton rubrum. Currently, around 2-3% of the U.S. population are suffering from onynchomycosis. Onychomycosis is majorly four types which include distal subungual onychomycosis, proximal subungual onychomycosis, and white superficial onychomycosis and candida infections of the nail. Globally, increased prevalence rate of diabetic patients and geriatric population, consistent raise in the prevalence of onychomycosis infections, rise in awareness among common people regarding diagnosis and treatment of  Onychomycosis, and development of novel medications are the prime growth drivers of Onychomycosis market. In addition, emerging economies such as China, India and others, will create new opportunities for global Onychomycosis market. However, Increased circulation of off label products and  Negligence towards this infection especially in less developed economies are the key restraints for global Onychomycosis treatment market.    

Onychomycosis Treatment Market

Geographically, Asia-Pacific is considered as an emerging market due to growing market penetration in this region. Increasing disposable income among population is also accounted for the Onychomycosis Treatment market growth in Asia-Pacific countries. Rest of the world (RoW) holds fourth position in the global Onychomycosis Treatment market due to poor economic and health condition in most of the African countries. RoW market growth will be fuelled by extensive increase in healthcare infrastructure in Brazil and Mexico.

This report identifies the onychomycosis treatment market size in for the year 2016-2021, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to onychomycosis treatment market.

This report is segmented into product type. Some of the major product type covered in this report are as follows:
  • Global Onychomycosis Treatment Market By Product Type: Tablet, Nail Paint, Device –Laser Beam and Ultra Sound, and Others
  • This report has been further segmented into major regions, which includes detailed analysis of each region such as North America, Europe, Asia-Pacific (APAC) and Rest of the World (RoW) covering all the major country level markets for Onychomycosis Treatment in each of the region.

This report identifies all the major companies operating in the global Onychomycosis Treatment market. Some of the major companies’ profiles in detail are as follows:

  • GlaxoSmithKline Pharmaceuticals Limited
  • Pfizer Inc.
  • Abbott Laboratories
  • Galaderma
  • Janssen Global Services, LLC
1. Onychomycosis Treatment Market - Overview
1.1. Definitions and Scope
2. Onychomycosis Treatment Market - Executive summary
2.1. Market Revenue, Market Size and Key Trends by Company
2.2. Key Trends by type of Application
2.3. Key Trends segmented by Geography
3. Onychomycosis Treatment Market 
3.1. Comparative analysis
3.1.1. Product Benchmarking - Top 10 companies
3.1.2. Top 5 Financials Analysis
3.1.3. Market Value split by Top 10 companies
3.1.4. Patent Analysis - Top 10 companies
3.1.5. Pricing Analysis 
4. Onychomycosis Treatment Market – Startup companies Scenario Premium
4.1. Top 10 startup company Analysis by
4.1.1. Investment
4.1.2. Revenue
4.1.3. Market Shares
4.1.4. Market Size and Application Analysis
4.1.5. Venture Capital and Funding Scenario
5. Onychomycosis Treatment Market – Industry Market Entry Scenario Premium
5.1. Regulatory Framework Overview
5.2. New Business and Ease of Doing business index
5.3. Case studies of successful ventures
5.4. Customer Analysis – Top 10 companies
6. Onychomycosis Treatment Market Forces
6.1. Drivers
6.2. Constraints
6.3. Challenges
6.4. Porters five force model
6.4.1. Bargaining power of suppliers
6.4.2. Bargaining powers of customers
6.4.3. Threat of new entrants
6.4.4. Rivalry among existing players
6.4.5. Threat of substitutes 
7. Onychomycosis Treatment Market -Strategic analysis
7.1. Value chain analysis
7.2. Opportunities analysis
7.3. Product life cycle
7.4. Suppliers and distributors Market Share
8. Onychomycosis Treatment Market – By Product Type (Market Size -$Million / $Billion)
8.1. Market Size and Market Share Analysis 
8.2. Application Revenue and Trend Research
8.3. Product Segment Analysis
8.3.1. Tablet
8.3.2. Nail Paint
8.3.3. Device –Laser Beam and Ultra Sound Migraines
8.3.4. Others
9. Onychomycosis Treatment - By Geography (Market Size -$Million / $Billion)
9.1. Onychomycosis Treatment Market - North America Segment Research
9.2. North America Market Research (Million / $Billion)
9.2.1. Segment type Size and Market Size Analysis 
9.2.2. Revenue and Trends
9.2.3. Application Revenue and Trends by type of Application
9.2.4. Company Revenue and Product Analysis
9.2.5. North America Product type and Application Market Size
9.2.5.1. U.S.
9.2.5.2. Canada 
9.2.5.3. Mexico 
9.2.5.4. Rest of North America
9.3. Onychomycosis Treatment - South America Segment Research
9.4. South America Market Research (Market Size -$Million / $Billion)
9.4.1. Segment type Size and Market Size Analysis 
9.4.2. Revenue and Trends
9.4.3. Application Revenue and Trends by type of Application
9.4.4. Company Revenue and Product Analysis
9.4.5. South America Product type and Application Market Size
9.4.5.1. Brazil  
9.4.5.2. Venezuela
9.4.5.3. Argentina
9.4.5.4. Ecuador
9.4.5.5. Peru
9.4.5.6. Colombia 
9.4.5.7. Costa Rica
9.4.5.8. Rest of South America
9.5. Onychomycosis Treatment - Europe Segment Research
9.6. Europe Market Research (Market Size -$Million / $Billion)
9.6.1. Segment type Size and Market Size Analysis 
9.6.2. Revenue and Trends
9.6.3. Application Revenue and Trends by type of Application
9.6.4. Company Revenue and Product Analysis
9.6.5. Europe Segment Product type and Application Market Size
9.6.5.1. U.K  
9.6.5.2. Germany 
9.6.5.3. Italy 
9.6.5.4. France
9.6.5.5. Netherlands
9.6.5.6. Belgium
9.6.5.7. Spain
9.6.5.8. Denmark
9.6.5.9. Rest of Europe
9.7. Onychomycosis Treatment – APAC Segment Research
9.8. APAC Market Research (Market Size -$Million / $Billion)
9.8.1. Segment type Size and Market Size Analysis 
9.8.2. Revenue and Trends
9.8.3. Application Revenue and Trends by type of Application
9.8.4. Company Revenue and Product Analysis
9.8.5. APAC Segment – Product type and Application Market Size
9.8.5.1. China 
9.8.5.2. Australia
9.8.5.3. Japan 
9.8.5.4. South Korea
9.8.5.5. India
9.8.5.6. Taiwan
9.8.5.7. Malaysia
10. Onychomycosis Treatment Market - Entropy
10.1. New product launches
10.2. M&A's, collaborations, JVs and partnerships
11. Onychomycosis Treatment Market – Industry / Segment Competition landscape Premium
11.1. Market Share Analysis
11.1.1. Market Share by Country- Top companies
11.1.2. Market Share by Region- Top 10 companies
11.1.3. Market Share by type of Application – Top 10 companies
11.1.4. Market Share by type of Product / Product category- Top 10 companies
11.1.5. Market Share at global level- Top 10 companies
11.1.6. Best Practises for companies
12. Onychomycosis Treatment Market – Key Company List by Country Premium
13. Onychomycosis Treatment Market Company Analysis
13.1. Market Share, Company Revenue, Products, M&A, Developments
13.2. GlaxoSmithKline Pharmaceuticals Limited
13.3. Pfizer Inc.
13.4. Abbott Laboratories
13.5. Galaderma
13.6. Janssen Global Services, LLC
13.7. NuvoLase, Inc
13.8. Cutera
13.9. Novartis AG
13.10. Bristol Meyer Squibb
13.11. Company 10 
13.12. Company 11
13.13. Company 12 and more
"*Financials would be provided on a best efforts basis for private companies"
14. Onychomycosis Treatment Market -Appendix
14.1. Abbreviations
14.2. Sources
15. Onychomycosis Treatment Market -Methodology Premium
15.1. Research Methodology
15.1.1. Company Expert Interviews
15.1.2. Industry Databases
15.1.3. Associations
15.1.4. Company News
15.1.5. Company Annual Reports
15.1.6. Application Trends
15.1.7. New Products and Product database
15.1.8. Company Transcripts
15.1.9. R&D Trends
15.1.10. Key Opinion Leaders Interviews
15.1.11. Supply and Demand Trends
List of Tables:

Table 1: Onychomycosis Treatment Market Overview 2019-2024
Table 2: Onychomycosis Treatment Market Leader Analysis 2018-2019 (US$)
Table 3: Onychomycosis Treatment Market Product Analysis 2018-2019 (US$)
Table 4: Onychomycosis Treatment Market End User Analysis 2018-2019 (US$)
Table 5: Onychomycosis Treatment Market Patent Analysis 2013-2018* (US$)
Table 6: Onychomycosis Treatment Market Financial Analysis 2018-2019 (US$)
Table 7: Onychomycosis Treatment Market Driver Analysis 2018-2019 (US$)
Table 8: Onychomycosis Treatment Market Challenges Analysis 2018-2019 (US$)
Table 9: Onychomycosis Treatment Market Constraint Analysis 2018-2019 (US$)
Table 10: Onychomycosis Treatment Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table 11: Onychomycosis Treatment Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table 12: Onychomycosis Treatment Market Threat of Substitutes Analysis 2018-2019 (US$)
Table 13: Onychomycosis Treatment Market Threat of New Entrants Analysis 2018-2019 (US$)
Table 14: Onychomycosis Treatment Market Degree of Competition Analysis 2018-2019 (US$)
Table 15: Onychomycosis Treatment Market Value Chain Analysis 2018-2019 (US$)
Table 16: Onychomycosis Treatment Market Pricing Analysis 2019-2024 (US$)
Table 17: Onychomycosis Treatment Market Opportunities Analysis 2019-2024 (US$)
Table 18: Onychomycosis Treatment Market Product Life Cycle Analysis 2019-2024 (US$)
Table 19: Onychomycosis Treatment Market Supplier Analysis 2018-2019 (US$)
Table 20: Onychomycosis Treatment Market Distributor Analysis 2018-2019 (US$)
Table 21: Onychomycosis Treatment Market Trend Analysis 2018-2019 (US$)
Table 22: Onychomycosis Treatment Market Size 2018 (US$)
Table 23: Onychomycosis Treatment Market Forecast Analysis 2019-2024 (US$)
Table 24: Onychomycosis Treatment Market Sales Forecast Analysis 2019-2024 (Units)
Table 25: Top Companies 2018 (US$)Onychomycosis Treatment Market, Revenue & Volume
Table 26: Product Launch 2018-2019Onychomycosis Treatment Market, Revenue & Volume
Table 27: Mergers & Acquistions 2018-2019Onychomycosis Treatment Market, Revenue & Volume


List of Figures:

Figure 1: Overview of Onychomycosis Treatment Market 2019-2024
Figure 2: Market Share Analysis for Onychomycosis Treatment Market 2018 (US$)
Figure 3: Product Comparison in Onychomycosis Treatment Market 2018-2019 (US$)
Figure 4: End User Profile for Onychomycosis Treatment Market 2018-2019 (US$)
Figure 5: Patent Application and Grant in Onychomycosis Treatment Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Onychomycosis Treatment Market 2018-2019 (US$)
Figure 7: Market Entry Strategy in Onychomycosis Treatment Market 2018-2019
Figure 8: Ecosystem Analysis in Onychomycosis Treatment Market 2018
Figure 9: Average Selling Price in Onychomycosis Treatment Market 2019-2024
Figure 10: Top Opportunites in Onychomycosis Treatment Market 2018-2019
Figure 11: Market Life Cycle Analysis in Onychomycosis Treatment Market
Figure 12: Global Onychomycosis Treatment Market - By Geography
Figure 13: Global Onychomycosis Treatment Market Value & Volume, By Geography, 2019-2024 ($) 
Figure 14: Global Onychomycosis Treatment Market CAGR, By Geography, 2019-2024 (%)
Figure 15: North America Onychomycosis Treatment Market Value & Volume, 2019-2024 ($)
Figure 16: US Onychomycosis Treatment Market Value & Volume, 2019-2024 ($)
Figure 17: US GDP and Population, 2018-2019 ($)
Figure 18: US GDP – Composition of 2018, By Sector of Origin
Figure 19: US Export and Import Value & Volume, 2018-2019 ($)
Figure 20: Canada Onychomycosis Treatment Market Value & Volume, 2019-2024 ($)
Figure 21: Canada GDP and Population, 2018-2019 ($)
Figure 22: Canada GDP – Composition of 2018, By Sector of Origin
Figure 23: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 24: Mexico Onychomycosis Treatment Market Value & Volume, 2019-2024 ($)
Figure 25: Mexico GDP and Population, 2018-2019 ($)
Figure 26: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 27: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 28: South America Onychomycosis Treatment Market Value & Volume, 2019-2024 ($)
Figure 29: Brazil Onychomycosis Treatment Market Value & Volume, 2019-2024 ($)
Figure 30: Brazil GDP and Population, 2018-2019 ($)
Figure 31: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 32: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 33: Venezuela Onychomycosis Treatment Market Value & Volume, 2019-2024 ($)
Figure 34: Venezuela GDP and Population, 2018-2019 ($)
Figure 35: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 36: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 37: Argentina Onychomycosis Treatment Market Value & Volume, 2019-2024 ($)
Figure 38: Argentina GDP and Population, 2018-2019 ($)
Figure 39: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 40: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 41: Ecuador Onychomycosis Treatment Market Value & Volume, 2019-2024 ($)
Figure 42: Ecuador GDP and Population, 2018-2019 ($)
Figure 43: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 44: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 45: Peru Onychomycosis Treatment Market Value & Volume, 2019-2024 ($)
Figure 46: Peru GDP and Population, 2018-2019 ($)
Figure 47: Peru GDP – Composition of 2018, By Sector of Origin
Figure 48: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 49: Colombia Onychomycosis Treatment Market Value & Volume, 2019-2024 ($)
Figure 50: Colombia GDP and Population, 2018-2019 ($)
Figure 51: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 52: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 53: Costa Rica Onychomycosis Treatment Market Value & Volume, 2019-2024 ($)
Figure 54: Costa Rica GDP and Population, 2018-2019 ($)
Figure 55: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 56: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 57: Europe Onychomycosis Treatment Market Value & Volume, 2019-2024 ($)
Figure 58: U.K Onychomycosis Treatment Market Value & Volume, 2019-2024 ($)
Figure 59: U.K GDP and Population, 2018-2019 ($)
Figure 60: U.K GDP – Composition of 2018, By Sector of Origin
Figure 61: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 62: Germany Onychomycosis Treatment Market Value & Volume, 2019-2024 ($)
Figure 63: Germany GDP and Population, 2018-2019 ($)
Figure 64: Germany GDP – Composition of 2018, By Sector of Origin
Figure 65: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 66: Italy Onychomycosis Treatment Market Value & Volume, 2019-2024 ($)
Figure 67: Italy GDP and Population, 2018-2019 ($)
Figure 68: Italy GDP – Composition of 2018, By Sector of Origin
Figure 69: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 70: France Onychomycosis Treatment Market Value & Volume, 2019-2024 ($)
Figure 71: France GDP and Population, 2018-2019 ($)
Figure 72: France GDP – Composition of 2018, By Sector of Origin
Figure 73: France Export and Import Value & Volume, 2018-2019 ($)
Figure 74: Netherlands Onychomycosis Treatment Market Value & Volume, 2019-2024 ($)
Figure 75: Netherlands GDP and Population, 2018-2019 ($)
Figure 76: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 77: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 78: Belgium Onychomycosis Treatment Market Value & Volume, 2019-2024 ($)
Figure 79: Belgium GDP and Population, 2018-2019 ($)
Figure 80: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 81: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 82: Spain Onychomycosis Treatment Market Value & Volume, 2019-2024 ($)
Figure 83: Spain GDP and Population, 2018-2019 ($)
Figure 84: Spain GDP – Composition of 2018, By Sector of Origin
Figure 85: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 86: Denmark Onychomycosis Treatment Market Value & Volume, 2019-2024 ($)
Figure 87: Denmark GDP and Population, 2018-2019 ($)
Figure 88: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 89: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 90: APAC Onychomycosis Treatment Market Value & Volume, 2019-2024 ($)
Figure 91: China Onychomycosis Treatment Market Value & Volume, 2019-2024
Figure 92: China GDP and Population, 2018-2019 ($)
Figure 93: China GDP – Composition of 2018, By Sector of Origin
Figure 94: China Export and Import Value & Volume, 2018-2019 ($)Onychomycosis Treatment Market China Export and Import Value & Volume, 2018-2019 ($)
Figure 95: Australia Onychomycosis Treatment Market Value & Volume, 2019-2024 ($)
Figure 96: Australia GDP and Population, 2018-2019 ($)
Figure 97: Australia GDP – Composition of 2018, By Sector of Origin
Figure 98: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 99: South Korea Onychomycosis Treatment Market Value & Volume, 2019-2024 ($)
Figure 100: South Korea GDP and Population, 2018-2019 ($)
Figure 101: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 102: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 103: India Onychomycosis Treatment Market Value & Volume, 2019-2024 ($)
Figure 104: India GDP and Population, 2018-2019 ($)
Figure 105: India GDP – Composition of 2018, By Sector of Origin
Figure 106: India Export and Import Value & Volume, 2018-2019 ($)
Figure 107: Taiwan Onychomycosis Treatment Market Value & Volume, 2019-2024 ($)
Figure 108: Taiwan GDP and Population, 2018-2019 ($)
Figure 109: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 110: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 111: Malaysia Onychomycosis Treatment Market Value & Volume, 2019-2024 ($)
Figure 112: Malaysia GDP and Population, 2018-2019 ($)
Figure 113: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 114: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 115: Hong Kong Onychomycosis Treatment Market Value & Volume, 2019-2024 ($)
Figure 116: Hong Kong GDP and Population, 2018-2019 ($)
Figure 117: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 118: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 119: Middle East & Africa Onychomycosis Treatment Market Middle East & Africa 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 120: Russia Onychomycosis Treatment Market Value & Volume, 2019-2024 ($)
Figure 121: Russia GDP and Population, 2018-2019 ($)
Figure 122: Russia GDP – Composition of 2018, By Sector of Origin
Figure 123: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 124: Israel Onychomycosis Treatment Market Value & Volume, 2019-2024 ($)
Figure 125: Israel GDP and Population, 2018-2019 ($)
Figure 126: Israel GDP – Composition of 2018, By Sector of Origin
Figure 127: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 128: Entropy Share, By Strategies, 2018-2019* (%)Onychomycosis Treatment Market
Figure 129: Developments, 2018-2019*Onychomycosis Treatment Market
Figure 130: Company 1 Onychomycosis Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 131: Company 1 Onychomycosis Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 132: Company 1 Onychomycosis Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 133: Company 2 Onychomycosis Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 134: Company 2 Onychomycosis Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 135: Company 2 Onychomycosis Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 136: Company 3Onychomycosis Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 137: Company 3Onychomycosis Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 138: Company 3Onychomycosis Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 139: Company 4 Onychomycosis Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 140: Company 4 Onychomycosis Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 141: Company 4 Onychomycosis Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 142: Company 5 Onychomycosis Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 143: Company 5 Onychomycosis Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 144: Company 5 Onychomycosis Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 145: Company 6 Onychomycosis Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 146: Company 6 Onychomycosis Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 147: Company 6 Onychomycosis Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 148: Company 7 Onychomycosis Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 149: Company 7 Onychomycosis Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 150: Company 7 Onychomycosis Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 151: Company 8 Onychomycosis Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 152: Company 8 Onychomycosis Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 153: Company 8 Onychomycosis Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 154: Company 9 Onychomycosis Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 155: Company 9 Onychomycosis Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 156: Company 9 Onychomycosis Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 157: Company 10 Onychomycosis Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 158: Company 10 Onychomycosis Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 159: Company 10 Onychomycosis Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 160: Company 11 Onychomycosis Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 161: Company 11 Onychomycosis Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 162: Company 11 Onychomycosis Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 163: Company 12 Onychomycosis Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 164: Company 12 Onychomycosis Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 165: Company 12 Onychomycosis Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 166: Company 13Onychomycosis Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 167: Company 13Onychomycosis Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 168: Company 13Onychomycosis Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 169: Company 14 Onychomycosis Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 170: Company 14 Onychomycosis Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 171: Company 14 Onychomycosis Treatment Market Net Sales Share, By Geography, 2018 (%)
Figure 172: Company 15 Onychomycosis Treatment Market Net Revenue, By Years, 2018-2019* ($)
Figure 173: Company 15 Onychomycosis Treatment Market Net Revenue Share, By Business segments, 2018 (%)
Figure 174: Company 15 Onychomycosis Treatment Market Net Sales Share, By Geography, 2018 (%)